Line 41: | Line 41: | ||
https://static.igem.org/mediawiki/2017/6/6b/T--Heidelberg--Team_Heidelberg_2017_graphical_abstract_JMu.png| | https://static.igem.org/mediawiki/2017/6/6b/T--Heidelberg--Team_Heidelberg_2017_graphical_abstract_JMu.png| | ||
Figure 2: Design of the Accessory Plasmids for the Evolution of Cas9| | Figure 2: Design of the Accessory Plasmids for the Evolution of Cas9| | ||
− | The AP consists of five subparts that are devided by homology regions for Gibson assembly (numbers). It carries an expression cassette for the transcription of a gRNA (between 1 and 5). GeneVI (2- | + | The AP consists of five subparts that are devided by homology regions for Gibson assembly (numbers). It carries an expression cassette for the transcription of a gRNA (between 1 and 5). GeneVI (2-4) is under control of a that can be activated by the Cas9-rpoZ in context with the respective gRNA. The whole plasmid can be produced with different origins of replication (4-5) to modulate the copy number and by exchanging the geneVI part with the RBS.}} |
{{Heidelberg/templateus/Tablebox| | {{Heidelberg/templateus/Tablebox| |
Revision as of 20:57, 1 November 2017
CRISPR Cas9
Phage Based Directed Evolution of Endonucleases
Introduction
Many of nowadays most threatening diseases are caused by mutations, epi mutations or other changes in the genome. Although medical research was always supplied by innovations in biological research and especially by the field of genetics, which developed rapidly during the last decades, there are still many diseases that cannot be cured or even treated adequately. Recently, the CRISPR/Cas9 technology raised hope of the scientific community to treat genetic disorders. This technique has dramatically simplified the way genomes can be manipulated. However, there are still many challenges to be surpassed. Cas9 and related endonucleases are enzymes, which are able to induce double strand breaks in the genome. Importantly, they only cut specific sequences to which they are guided by a so called guideRNA (gRNA). A gRNA consists of a 3' scaffold, which is obligatory for the binding of the Cas9 enzyme, a protospacer sequence, and 20 nucleotides at the 5'-end that are complementary to the target DNA. Once the Cas9 endonuclease binds to the DNA, it cleaves three nucleotides upstream of the protospacer 3'-end. This system allows to target virtually any position in any genome. However, there is one major restriction in the applicability of this system. Only sequences can be targeted that carry a specific recognition motif directly downstream of the spacer, the protospacer adjacent motif (PAM). In case of Cas9, the consensus PAM is NGGThe Idea
To prove our hypothesis, we planned a circuit for the directed evolution of PAM specificity of Cas9 (Fig. 1). The main challenge was to link transcription activation to the binding of Cas9. We chose a system, which contains a dCas9 fused to a RNA polymerase Ω subunit (rpoZ)Phage Based in vivo Evolution with gene VI
One of the major challenges in the context of transcription activation with help of the rpoZ is leaky expression. This is a serious problem for PACE, because if gene III is expressed in absence of phage, the cell may become resistant to phage infectionOur Accessory Plasmids for PACE of Endonucleases The different accessory plasmids that were cloned in the context of this project are shown. The constructs differ in their copy number and the strength of their RBSs.
Puri-ID | AP | Regulatory Sequence | RBS of geneIV | Origin of replication | gRNA cassette | PAM |
---|---|---|---|---|---|---|
821 | AP_Cas9_pSC101_NNNN_SD8_GVI | minimal promoter downstram of the dCas9 target sequence | SD8 | pSC101 | gRNA expression cassette | NNNN |
822 | AP_Cas9_pSC101_NNNN_sd8_GVI | minimal promoter downstram of the dCas9 target sequence | sd8 | pSC101 | gRNA expression cassette | NNNN |
823 | AP_Cas9_pSC101_NNNN_sd6_GVI | minimal promoter downstram of the dCas9 target sequence | sd6 | pSC101 | gRNA expression cassette | NNNN |
824 | AP_Cas9_pSC101_NNNN_SD4_GVI | minimal promoter downstram of the dCas9 target sequence | sd4 | pSC101 | gRNA expression cassette | NNNN |
825 | AP_Cas9_pSC101_NNNN_sd2_GVI | minimal promoter downstram of the dCas9 target sequence | sd2 | pSC101 | gRNA expression cassette | NNNN |
826 | AP_Cas9_pSC101_NGAN_SD8_GVI | minimal promoter downstram of the dCas9 target sequence | SD8 | pSC101 | gRNA expression cassette | NGAN |
829 | AP_Cas9_pSC101_NGAN_SD4_GVI | minimal promoter downstram of the dCas9 target sequence | sd4 | pSC101 | gRNA expression cassette | NGAN |
830 | AP_Cas9_pSC101_NGAN_sd2_GVI | minimal promoter downstram of the dCas9 target sequence | sd2 | pSC101 | gRNA expression cassette | NGAN |